Associations of mid-pregnancy HbA1c with gestational diabetes and risk of adverse pregnancy outcomes in high-risk Taiwanese women
Open accessThe DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Abstract
BACKGROUND: The objective of this study was to investigate the associations among the mid-pregnancy glycated hemoglobin A1c (HbA1c) level, gestational diabetes (GDM), and risk of adverse pregnancy outcomes in women without overt diabetes and with positive 50-g, 1-h glucose challenge test (GCT) results (140 mg/dL or greater). METHODS: This prospective study enrolled 1,989 pregnant Taiwanese women. A two-step approach, including a 50-g, 1-h GCT and 100-g, 3-h oral glucose tolerance test (OGTT), was employed for the diagnosis of GDM at weeks 23-32. The mid-pregnancy HbA1c level was measured at the time the OGTT was performed. A receiver operating characteristic (ROC) curve was used to determine the relationship between the mid-pregnancy HbA1c level and GDM. Multiple logistic regression models were implemented to assess the relationships between the mid-pregnancy HbA1c level and adverse pregnancy outcomes. RESULTS: An ROC curve demonstrated that the optimal mid-pregnancy HbA1c cut-off point to predict GDM, as diagnosed by the Carpenter-Coustan criteria using a two-step approach, was 5.7%. The area under the ROC curve of the mid-pregnancy HbA1c level for GDM was 0.70. Compared with the levels of 4.5-4.9%, higher mid-pregnancy HbA1c levels (5.0-5.4, 5.5-5.9, 6.0-6.4, 6.5-6.9, and >7.0%) were significantly associated with increased risks of gestational hypertension or preeclampsia, preterm delivery, admission to the neonatal intensive care unit, low birth weight, and macrosomia (the odds ratio [OR] ranges were 1.20-9.98, 1.31-5.16, 0.88-3.15, 0.89-4.10, and 2.22-27.86, respectively). CONCLUSIONS: The mid-pregnancy HbA1c level was associated with various adverse pregnancy outcomes in high-risk Taiwanese women. However, it lacked adequate sensitivity and specificity to replace the two-step approach in the diagnosis of GDM. The current study comprised a single-center prospective study; thus, additional, randomized control design studies are required.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In studies of individuals without preexisting diabetes, increasing A1C levels within the normal range are associated with adverse outcomes (38).”
From 15. Management of Diabetes in Pregnancy: Standards of Care in Diabetes—2024 (2024) · cites this paper as [38]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Criteria for screening tests for gestational diabetes
Carpenter, M. W., & Coustan, D. R. (1982) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(82)90349-0 · Cited by 1,924
Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults
Selvin, E., Steffes, M. W., Zhu, H., Matsushita, K., Wagenknecht, L., Pankow, J., Coresh, J., & Brancati, F. L. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0908359 · Cited by 1,544
Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study
Lowe, L. P., Metzger, B. E., Dyer, A. R., Lowe, J., McCance, D. R., Lappin, T. R. J., Trimble, E. R., Coustan, D. R., Hadden, D. R., Hod, M., et al. (2012) · Diabetes Care · doi:10.2337/dc11-1687 · Cited by 367
Hughes, R. C. E., Moore, M. P., Gullam, J. E., Mohamed, K., & Rowan, J. (2014) · Diabetes Care · doi:10.2337/dc14-1312 · Cited by 238
Glycated hemoglobin measurement and prediction of cardiovascular disease
Di Angelantonio, E., Gao, P., Khan, H., Butterworth, A. S., Wormser, D., Kaptoge, S., Kondapally Seshasai, S. R., Thompson, A., Sarwar, N., Willeit, P., et al. (2014) · JAMA · doi:10.1001/jama.2014.1873 · Cited by 231
Utility of HbA1c for diagnosis of gestational diabetes mellitus
Rajput, R., YogeshYadav, Rajput, M., & Nanda, S. (2012) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2012.02.018 · Cited by 127
Is There a Role for HbA1c in Pregnancy?
Hughes, R. C. E., Rowan, J., & Florkowski, C. M. (2016) · Current Diabetes Reports · doi:10.1007/s11892-015-0698-y · Cited by 127
Gestational diabetes: a reappraisal of HBA1c as a screening test
Agarwal, M. M., Dhatt, G. S., Punnose, J., & Koster, G. (2005) · Acta Obstetricia et Gynecologica Scandinavica · doi:10.1080/j.0001-6349.2005.00650.x · Cited by 77
HbA1c Test as a Tool in the Diagnosis of Gestational Diabetes Mellitus
Renz, P. B., Cavagnolli, G., Weinert, L. S., Silveiro, S. P., & Camargo, J. L. (2015) · PLOS ONE · doi:10.1371/journal.pone.0135989 · Cited by 76
A New Zealand Linkage Study Examining the Associations Between A1C Concentration and Mortality
Brewer, N., Wright, C. S., Travier, N., Cunningham, C. W., Hornell, J., Pearce, N., & Jeffreys, M. (2008) · Diabetes Care · doi:10.2337/dc07-2374 · Cited by 67
Cited by
15. Management of Diabetes in Pregnancy: Standards of Medical Care in Diabetes—2022
American Diabetes Association Professional Practice Committee (2022) · Diabetes Care · doi:10.2337/dc22-s015 · Cited by 504
Epidemiology and management of gestational diabetes
Sweeting, A., Hannah, W., Backman, H., Catalano, P., Feghali, M., Herman, W. H., Hivert, M.-F., Immanuel, J., Meek, C., Oppermann, M. L., et al. (2024) · The Lancet · doi:10.1016/s0140-6736(24)00825-0 · Cited by 431
14. Management of Diabetes in Pregnancy:Standards of Medical Care in Diabetes—2020
American Diabetes Association (2020) · Diabetes Care · doi:10.2337/dc20-s014 · Cited by 381
15. Management of Diabetes in Pregnancy:Standards of Care in Diabetes—2023
ElSayed, N. A., Aleppo, G., Aroda, V. R., Bannuru, R. R., Brown, F. M., Bruemmer, D., Collins, B. S., Hilliard, M. E., Isaacs, D., Johnson, E. L., et al. (2023) · Diabetes Care · doi:10.2337/dc23-s015 · Cited by 284
14. Management of Diabetes in Pregnancy:Standards of Medical Care in Diabetes—2021
American Diabetes Association (2021) · Diabetes Care · doi:10.2337/dc21-s014 · Cited by 268
14. Management of Diabetes in Pregnancy: Standards of Medical Care in Diabetes—2019
American Diabetes Association (2019) · Diabetes Care · doi:10.2337/dc19-s014 · Cited by 265
“the normal range is associated with adverse outcomes (23).”
Background15. Management of Diabetes in Pregnancy: Standards of Care in Diabetes—2025
American Diabetes Association Professional Practice Committee, ElSayed, N. A., McCoy, R. G., Aleppo, G., Balapattabi, K., Beverly, E. A., Briggs Early, K., Bruemmer, D., Echouffo-Tcheugui, J. B., Ekhlaspour, L., et al. (2025) · Diabetes Care · doi:10.2337/dc25-s015 · Cited by 252
15. Management of Diabetes in Pregnancy: Standards of Care in Diabetes—2024
American Diabetes Association Professional Practice Committee, ElSayed, N. A., Aleppo, G., Bannuru, R. R., Bruemmer, D., Collins, B. S., Ekhlaspour, L., Hilliard, M. E., Johnson, E. L., Khunti, K., et al. (2024) · Diabetes Care · doi:10.2337/dc24-s015 · Cited by 232
15. Management of Diabetes in Pregnancy: Standards of Care in Diabetes—2026
Bajaj, M. S., McCoy, R. G., Balapattabi, K., Bannuru, R. R., Bellini, N. J., Bennett, A. K., Beverly, E. A., Early, K. B., Brown, F. M., ChallaSivaKanaka, S., et al. (2025) · Diabetes Care · doi:10.2337/dc26-s015 · Cited by 176
Gestational Diabetes Mellitus and Preeclampsia: Correlation and Influencing Factors
Yang, Y., & Wu, N. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.831297 · Cited by 155
“It is controversial whether HbA1c level in the second trimester of pregnancy is related to the occurrence of PE, the secondary analysis of HAPO and a retrospective study showed that the HbA1c level during OGTT was related to the occurrence of PE (99, 100).”
Pillay, J., Donovan, L., Guitard, S., Zakher, B., Gates, M., Gates, A., Vandermeer, B., Bougatsos, C., Chou, R., & Hartling, L. (2021) · JAMA · doi:10.1001/jama.2021.10404 · Cited by 99
Tsakiridis, I., Giouleka, S., Mamopoulos, A., Kourtis, A., Athanasiadis, A., Filopoulou, D., & Dagklis, T. (2021) · Obstetrical & Gynecological Survey · doi:10.1097/ogx.0000000000000899 · Cited by 94
“86, respectively).(42) Moreover, the ADA states that, if this target (6%) cannot be achieved without hypoglycemic events, a threshold of 7% is acceptable.”
BackgroundZheng, T., Ye, W., Wang, X., Li, X., Zhang, J., Little, J., Zhou, L., & Zhang, L. (2019) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-019-2374-8 · Cited by 91
Incidence and trend of preterm birth in China, 1990–2016: a systematic review and meta-analysis
Jing, S., Chen, G., Gan, Y., Vogel, J. P., & Zhang, J. (2020) · BMJ Open · doi:10.1136/bmjopen-2020-039303 · Cited by 88
Lai, M., Weng, J., Yang, J., Gong, Y., Fang, F., Li, N., Kang, M., Xu, X., & Wang, Y. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1174239 · Cited by 62
“2% of GDM cases have an HbA1c level < 6% (13, 14).”
BackgroundHbA1c Measured in the First Trimester of Pregnancy and the Association with Gestational Diabetes
Hinkle, S. N., Tsai, M. Y., Rawal, S., Albert, P. S., & Zhang, C. (2018) · Scientific Reports · doi:10.1038/s41598-018-30833-8 · Cited by 57
Renz, P. B., Chume, F. C., Timm, J. R. T., Pimentel, A. L., & Camargo, J. L. (2019) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2018-1191 · Cited by 54
“In a prospective study that enrolled 1989 pregnant Taiwanese women [50], the AUC was 0.”
Time in range in pregnancy: is there a role?
Wyckoff, J. A., & Brown, F. M. (2021) · Diabetes Spectrum · doi:10.2337/ds20-0103 · Cited by 39
The association between maternal HbA1c and adverse outcomes in gestational diabetes
Muhuza, M. P. U., Zhang, L., Wu, Q., Qi, L., Chen, D., & Liang, Z. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1105899 · Cited by 38
“0%(42mmol/mol) and macrosomia in Asian women with GDM, similar to our findings (20, 21, 25).”
ResultAdverse maternal and neonatal outcomes in pregnant women with abnormal glucose metabolism
Li, M.-F., Ma, L., Yu, T.-P., Zhu, Y., Chen, M.-Y., Liu, Y., & Li, L.-X. (2020) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2020.108085 · Cited by 31
Amaefule, C. E., Sasitharan, A., Kalra, P., Iliodromoti, S., Huda, M. S. B., Rogozińska, E., Zamora, J., & Thangaratinam, S. (2020) · Current Opinion in Obstetrics & Gynecology · doi:10.1097/gco.0000000000000648 · Cited by 31
Liu, X., Wu, N., & Al-Mureish, A. (2021) · International Journal of General Medicine · doi:10.2147/ijgm.s296316 · Cited by 28
Siddiqui, S., Waghdhare, S., Goel, C., Panda, M., Soneja, H., Sundar, J., Banerjee, M., Jha, S., & Dubey, S. (2018) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2018.12.023 · Cited by 27
Lai, Y., Chen, H., Du, Z., Zhou, S., Xu, W., & Li, T. (2020) · Annals of Translational Medicine · doi:10.21037/atm-20-5464 · Cited by 24
“demonstrated that HbA1c level of first-trimester and midpregnancy (23–32 weeks) lacks the sensitivity and specificity in the diagnosis of GDM, respectively (14,15).”
BackgroundDiabetes mellitus type 1 in adults
Dedov, I. I., Shestakova, M. V., Mayorov, A. Y., Шамхалова, М. Ш., Nikonova, T. V., Sukhareva, O. Y., Пекарева, Е. В., Ibragimova, L. I., Mikhina, M. S., Galstyan, G. R., et al. (2020) · Diabetes Mellitus · doi:10.14341/dm12505 · Cited by 26
Ouyang, P., Duan, S., You, Y., Jia, X., & Yang, L. (2023) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-023-05670-x · Cited by 19
“70 and significantly associated with increased risks of neonatal complications like neonatal intensive care unit, low birth weight, and macrosomia [29].”
BackgroundPoo, Z. X., Wright, A., Du, R., & Singh, R. (2018) · Obstetric Medicine · doi:10.1177/1753495x18795984 · Cited by 19
Importance of early elevated maternal HbA1c levels in identifying adverse fetal and neonatal events
Yu, H., Wang, J., Shrestha, Y., Hu, Y., Ma, Y., Ren, L., Zhang, J., & Li, J. (2019) · Placenta · doi:10.1016/j.placenta.2019.07.008 · Cited by 16
Wang, X., Zhang, S., Yu, W., Li, G., Li, J., Ji, J., Mi, Y., & Luo, X. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1238873 · Cited by 15
“In addition, one third of pre-pregnancy obese women had higher glycated hemoglobin (HbA1c) levels at delivery (12), which were associated with gestational hypertension, preterm birth, and low birth weight (13).”
BackgroundGlucose Treatment Targets in Pregnancy - A Review of Evidence and Guidelines
Byford, A. R., Forbes, K. A., & SCOTT, E. M. (2022) · Current Diabetes Reviews · doi:10.2174/1573399818666220422083935 · Cited by 13
Identification of MODY among patients screened for gestational diabetes: a clinician’s guide
Urbanová, J., Brunerová, L., Nunes, M. A., & Brož, J. (2020) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-020-05626-y · Cited by 11
Deng, Y., Cheng, D., Liao, G., Tan, X., & Yang, J. (2023) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-023-05980-0 · Cited by 10
“HbA1c testing was conducted at least once using a standardized laboratory procedure as described by Ho. et al. [14] Blood was collected in the morning after an 8-hour fast and sent to our central laboratory which is equipped with the National Glycohemoglobin Stan-dardization Program (NGSP)…”
MethodReyes-Muñoz, E., Guardo, F. D., Ciebiera, M., Kahramanoğlu, İ., Sathyapalan, T., Lin, L.-T., Shah, M., Karaman, E., Fan, S., Zito, G., et al. (2019) · Current Pharmaceutical Design · doi:10.2174/1381612825666190722155512 · Cited by 11
Wu, H., Zhang, L., Xie, Z., Cai, H., Zhang, J., & Yu, L. (2025) · International Journal of Women s Health · doi:10.2147/ijwh.s500531 · Cited by 7
“32 43 Our study found that an HbA1c threshold of ≥5.5% was independently associated with a nearly five-fold increased risk of PE, supporting the findings of previous research.”
InfluentialHemoglobina glicada (HbA1c) no diabetes mellitus gestacional
Renz, P. B. (2018) · Americanae (AECID Library) · Cited by 7
Hemoglobin A1c as a screening strategy for gestational diabetes
Schaible, B., Calhoun, B. C., Bush, S., Ramser, B., Seybold, D. J., Broce, M., Fending, P., White, A., Williams, D. L., & Bracero, L. A. (2018) · Medical and Dental Research · doi:10.15761/mdr.1000103 · Cited by 6
Priya, G., Bajaj, S., Kalra, B., Coetzee, A., Kalra, S., Dutta, D., Lim, V., Divakar, H., Deshmukh, V. C., Mehta, R., et al. (2021) · Journal of Family Medicine and Primary Care · doi:10.4103/jfmpc.jfmpc_653_21 · Cited by 6
“[41] Ho et al.[42] reported HbA1c levels were associated with the risk of gestational hypertension, preeclampsia, preterm delivery, low birth weight as well as macrosomia and the need for neonatal intensive care.”
BackgroundZhang, J., Zhou, F., Xu, T., Xu, J., Li, Y., Lin, L., Cao, Q., & Wang, X. (2022) · Journal of obstetrics and gynaecology research · doi:10.1111/jog.15170 · Cited by 6
“Ho et al.(16) Taiwan, China Prospective No Yes 24–28 24–28 HPLC CC 1982”
BackgroundKaur, N., Goel, P., Mehra, R., & Kaur, J. (2019) · International Journal of Reproduction Contraception Obstetrics and Gynecology · doi:10.18203/2320-1770.ijrcog20193794 · Cited by 5
“7%.(23) In another study done on 100 patients by Sen gupta et al, there was significant increase in the incidence of vulvovaginitis, preterm delivery, polyhydramnios and post partum haemorrhage when the HbA1c level was > 6% in 2 and 3 trimester in patients with GDM or pregestational diabetes.”
BackgroundHan, N., Yuan, Z., Zhao, H., Chang, X., Chen, Y., Zhang, M., & Wang, Y. (2024) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.1080/14767058.2024.2312447 · Cited by 5
“…HbA1c category of 4.5– 4.9%, higher HbA1c levels were significantly associated with increased risks of Hypertensive disorders of pregnancy, preterm delivery, low birth weight, and macro-somia (OR ranges of 1.20–9.98, 1.31–5.16, 0.89–4.10, and 2.22–27.86, respectively; all trend p values <.05) [30].”
InfluentialEarly screening biomarker HbA1c and Hematocrit for gestational diabetes mellitus
Tripathy, S., Murugesan, A., Natarajan, K., Ramraj, B., & Mohapatra, S. (2021) · Clinical Epidemiology and Global Health · doi:10.1016/j.cegh.2021.100945 · Cited by 5
Khambule, L., Chauke, L., Crowther, N. J., & George, J. A. (2025) · International Journal of Gynecology & Obstetrics · doi:10.1002/ijgo.70370 · Cited by 4
Lin, Y., Chen, R., Ge, Y., Brunner, J., Hopke, P. K., Miller, R. K., Thornburg, L. L., Stevens, T. P., Barrett, E. S., Harrington, D. K., et al. (2024) · Environmental Science & Technology · doi:10.1021/acs.est.4c05612 · Cited by 4
Kabir, Y., Shaykhon, N., & Atkin, S. L. (2024) · Cureus · doi:10.7759/cureus.53207 · Cited by 3
“Ho et al. [30] reported that HbA1c might be associated with adverse events in pregnancy around the second trimester.”
BackgroundSekine, T., Tsuchiya, K., Uchinuma, H., Horiuchi, S., Kushima, M., Otawa, S., Yokomichi, H., Miyake, K., Akiyama, Y., Ooka, T., et al. (2021) · Journal of Diabetes Investigation · doi:10.1111/jdi.13701 · Cited by 3
Association of Normal-Range Hemoglobin A1c Value During Midpregnancy with Adverse Birth Outcomes
Zhang, L., Zhai, R., Huo, Z., Wei, Z., Zhang, Z., Wei, R., & Man, D. (2021) · International Journal of General Medicine · doi:10.2147/ijgm.s313952 · Cited by 3
Shankar, A., Sumathy, S., & Santhini Gopalakrishnan, S. (2021) · Romanian Journal of Diabetes Nutrition and Metabolic Diseases · Cited by 3
Salman, B. A., Abid-Alkareem, I. H., & Marbut, M. M. (2023) · Aalborg Academy Journal of Medical Sciences · Cited by 2
Glycated Hemoglobin: A Useful Screening Tool for Gestational Diabetes Mellitus
Mandrelle, K., Arora, G. K., & Jacob, J. J. (2023) · Journal of South Asian Federation of Obstetrics and Gynaecology · doi:10.5005/jp-journals-10006-2201 · Cited by 1
Determination of Hba1c, BMI and Blood Pressure Changes in Women with Gestational Diabetes Mellitus
Mahmood, H. A., & Shaher, W. S. (2024) · Scientific Research Journal of Medical Sciences · doi:10.47310/srjms.2024.v04i01.010 · Cited by 1
Bongomin, F., Kyazze, A. P., Ninsiima, S., Olum, R., Nattabi, G., Nabakka, W., Kukunda, R., Batte, C., Ssekamatte, P., Baluku, J. B., et al. (2020) · Emerald Open Research · doi:10.35241/emeraldopenres.14014.1 · Cited by 1
Ru, Z., Ge, Z., Hu, J., Zhu, D., Bi, Y., & Shen, S. (2022) · Research Square · doi:10.21203/rs.3.rs-2238988/v1 · Cited by 1
Gopalan, U., Kanukolanu, R. N., & Rajagopalan, B. (2021) · Indian Journal of Obstetrics and Gynecology Research · doi:10.18231/j.ijogr.2021.038
Glycated hemoglobin as a predictor for gestational diabetes
Emam, R. M., Nassef, A., & Abou-Raia, H. (2021) · Al-Azhar Assiut Medical Journal · doi:10.4103/azmj.azmj_114_20
KAPLAN, İ. (2022) · Ege Tıp Bilimleri Dergisi · doi:10.33713/egetbd.1079188
HbA1c as an Early Diagnostic Marker in Gestational Diabetes Mellitus: A Retrospective Study
Saboor, R., Khan, F. A., Khan, I., Lail, A., Bhutto, A., & Kumar, R. (2022) · Pakistan Journal of Medical and Health Sciences · doi:10.53350/pjmhs22169909
Association between mid-pregnancy HbA1c values and anemia in women without gestational diabetesPreprint
Zhai, R., Wei, R., Wei, Z., Huo, Z., Zhang, Z., Man, D., Wang, F., & Zhang, L. (2023) · Research Square · doi:10.21203/rs.3.rs-2264811/v1
Pavithra, R., Sreelatha, S., & Pooja, P. (2023) · International Journal of Reproduction Contraception Obstetrics and Gynecology · doi:10.18203/2320-1770.ijrcog20230122
Bongomin, F., Kyazze, A. P., Ninsiima, S., Olum, R., Nattabi, G., Nabakka, W., Kukunda, R., Batte, C., Ssekamatte, P., Baluku, J. B., et al. (2020) · Emerald Open Research · doi:10.1108/eor-02-2023-0019
Kuhn, C. (2024) · Common Library Network (Der Gemeinsame Bibliotheksverbund) · doi:10.22032/dbt.68556
Monjardin-Soria, A. K. S., & Tan, C. C. Y. (2022) · Philippine Journal of Internal Medicine · doi:10.65564/pjim.951eb1f16f
Dumanlı, G. Y., Tabak, Ö., Kumbasar, A., & Talmaç, M. A. (2026) · Cerrahpasa Medical Journal · doi:10.5152/cjm.2026.25099
“21 These disparate findings illustrate how timing, population, and endpoint selection alter apparent associations.”
Insights into Periconceptional and Prenatal Care to Prevent Great Obstetrical Syndromes
Renzo, G. C. D., Tosto, V., Tsibizova, V., Clerici, G., & Meyyazhagan, A. (2026) · Springer eBooks · doi:10.1007/978-3-032-05381-7_28
Ethnic Differences in Pregnancy Complications Among Women with Gestational Diabetes
Filardi, T., Galoppi, P., Gorini, S., Mappa, I., Rizzo, G., & Morano, S. (2026) · Medical Sciences · doi:10.3390/medsci14040482
“Although the role of HbA1c as a reliable predictor of unfavorable outcomes in GDM-complicated pregnancies is not yet fully established, emerging evidence suggested a possible link between specific HbA1c thresholds across different stages of pregnancy and gestational complications [40–42].”
Tengrattanaprasert, K. (2025) · Journal of Medicine and Public Health, Ubon Ratchathani University
Metadata
- Authors
- Ho, Y.-R., Wang, P., Lu, M.-C., Tseng, S.-T., Yang, C.-P., & Yan, Y.-H.
- Affiliations
- Kuang Tien General Hospital (TW)
- Chia-Yi Christian Hospital (TW)
- Providence University (TW)
- National Taiwan University (TW)
- Corresponding author
- Yang, Chun-Pai
- Yan, Yuan-Horng
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2017-05-15
- Volume
- 12
- Issue
- 5
- Pages
- e0177563
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC5432166
- OpenAlex
- W2614404832
- Cited by
- 59
- References
- 27
- Citations by year
- 2026: 2 · 2025: 3 · 2024: 5 · 2023: 10 · 2022: 8 · 2021: 11 · 2020: 9 · 2019: 6 · 2018: 5
- FWCI
- 6.44
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS ONE (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Topics
- Health Sciences › Medicine › Obstetrics and Gynecology › Gestational Diabetes Research and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- HbA1c, gestational diabetes mellitus, second trimester, adverse pregnancy outcomes, gestational hypertension, preeclampsia, preterm birth, neonatal intensive care admission, low birth weight, macrosomia, glucose challenge test, oral glucose tolerance test, GDM diagnosis, high-risk pregnancy, Taiwanese women
- MeSH terms
- Adult, Female, Glycated Hemoglobin, Humans, Infant, Newborn, Pregnancy, Pregnancy Outcome, ROC Curve, Taiwan, Odds Ratio, Diabetes, Gestational, Asian People, Public Health Surveillance
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.